TY  - GEN
AU  - Kumarakulasinghe,Nesaretnam Barr
AU  - Syn,Nicholas
AU  - Soon,Yu Yang
AU  - Asmat,Atasha
AU  - Zheng,Huili
AU  - Loy,En Yun
AU  - Pang,Brendan
AU  - Soo,Ross Andrew
TI  - EGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: a retrospective database analysis of potential drug interaction
SN  - 1949-2553
PY  - 2018///0221
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Chi-Square Distribution
KW  - Databases, Factual
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Drug Interactions
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Erlotinib Hydrochloride
KW  - pharmacology
KW  - Female
KW  - Gefitinib
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Karnofsky Performance Status
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Mutation
KW  - Proportional Hazards Models
KW  - Protein Kinase Inhibitors
KW  - Proton Pump Inhibitors
KW  - Quinazolines
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Risk Factors
KW  - Singapore
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.18632/oncotarget.13458
ER  -